Survey on salt iodine content at household level of Chidambaram, Cuddalore district, Tamilnadu
Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 10
Abstract
Around 43% of the population does not consume adequate amounts of iodine which make them vulnerable to physical and mental disorder. UNICEF estimates that less than 20% of households in the developing world were using iodized salt in the early 1990s, and by 2000, the average had jumped to some 70%. By 2006, around 120 countries were implementing salt iodization programs.
Authors and Affiliations
Aravindan. J| Post Graduate Department of Community Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar India, N. Ethirajan| faculty, Department of community Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar India, John William Felix| faculty, Department of community Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar India, T. K. Senthil Murugan| faculty, Department of community Medicine, Rajah Muthiah Medical College, Annamalai University, Annamalai Nagar India
PHARMACEUTICAL TASTE MASKING TECHNOLOGIES OF BITTER DRUGS: A CONCISE REVIEW
Taste refers to a perception arising from the stimulation of taste buds present on the surface of the tongue. Humans can distinguish among five components of taste: sourness, saltiness, sweetness, bitterness, and umami (...
Antibacterial activity of Citrus aurantium leaf essential oil against S.aureus and MRSA
Plants based antimicrobials effective in the treatment of infectious diseases and also devoid of side effects which associated with synthetic one. To evaluate antibacterial effect of Citrus aurantium leaf essential oil a...
FORMULATION AND OPTIMIZATION OF ONDANSETRON HYDROCHLORIDE ORODISPERSIBLE TABLETS
The demand for mouth dissolving tablets has been growing, during the last decade especially for geriatric and pediatric patients because of swallowing difficulties. Orodispersible tablets of Ondansetron hydrochloride wer...
POMALIDOMIDE: A NOVEL PROMISING IMMUNOMODULATORY AGENT IN THE TREATMENT OF REFRACTORY AND RELAPSED MULTIPLE MYELOMA
Revival of thalidomide in the treatment of multiple myeloma (MM) has paved a path to search for compounds with increased antiangiogenic and anti-tumor effects, but decreased side-effects resulting in the development of t...
A DRUG: URTICA DIOICA